Get started
SELECT SECTOR SPDR TRUST HEALTHCARESELECT SECTOR SPDR TRUST HEALTHCARESELECT SECTOR SPDR TRUST HEALTHCARE

SELECT SECTOR SPDR TRUST HEALTHCARE

No trades
See on Supercharts
Overview Analysis News
Ideas
Discussions Technicals Seasonals

XLV trade ideas

Healthcare Critical LevelTechnical Analysis The 200ema has been tested several times, and has worked very well as a mid-term support level. Risk reward ratio is easy to set-up with a 3:1 ratio approximately. Sector & Industry Analysis It is important to note that the industries inside the sector have different performance, which has been very useful to analyze what the market thinks of the risk of healthcare with the election coming up. The following list is the Healthcare Industries with a 6-month performance % move, as well as a some good ETF to follow/trade: Healthcare Technology --> +56% // have not found appropriate ETF. Biotechnology --> +21% // XBI (smaller biotech), IBB (large-cap biotech), ARKG (genomics) Healthcare Equipment --> +19% // IHI Healthcare Providers --> +5.51% // IHF Pharmaceuticals --> -1.3% // IHE
AMEX:XLV
by dorfmanmaster
Health Care ETF Sneaks to New HighsThe SPDR Health Care ETF broke above its pre-Covid highs on July 17. Now it’s pulled back and is bouncing at those old levels. Is a stealth breakout taking place? XLV has also formed a bullish ascending triangle, which it’s broken to the upside. Health care is interesting because it lost more than 1 million workers amid the coronavirus lockdowns (according to Labor Department data). It’s not as bad as hotels or airlines, but it was clearly disrupted. However unlike hotels and airlines, health care is a non-cyclical part of the economy that can still work during a recession. And recent numbers show it might be rebounding quickly. For example hospital operator HCA is up 35 percent in the last month, partially because admittances are rebounding. Equipment providers like Intuitive Surgical and Abiomed have also jumped as procedures resume. Overall health-care isn’t the most exciting sector. But it is a big chunk of the economy. Like housing, it’s likely to recover much more quickly from the pandemic than other sectors. That may keep the buyers engaged, especially if XLV holds the recent low of $104.43.
AMEX:XLVLong
by TradeStation
XLV prepare to Long, double bottom Existing condition: 1. Weekly demand zone confirmed 2. 15 min Chart double bottom formed Buy 75.5 or better price Stop: 73.5 Target 1: 81.5; risk:reward=1:3 Target 2: 86; risk:reward=1:5 This is a trading school homework. I need 6 months to practice trading plan. If you like it, thank you for your support. Please use SIM/Demo account to try it, until my trading plans get high winning rate. Sum of my ideas: 1 winner, 1 loser, 4 active, 8 cancelled, 4 pending for condition, 1 analysis only.
AMEX:XLVLong
by PlanTradePlanMM
Healthcare probably going to take a hit this weekCongress's coronavirus stimulus deal reached Friday night included a provision requiring health insurers to bear the full cost of coronavirus test kits and to waive copays. The federal government will pay the cost for the uninsured. This will probably hurt health insurers Monday, though it might be good for service providers. Here's another piece of bad news: xenophobia related to the virus has angered the Chinese government, and China’s official newspaper Xinhua published a threat to cut off supply chains for the US pharmaceutical industry. If China followed through on this threat, there could be big US drug shortages, which would be bad for pharmaceutical and healthcare companies. The whole economy will be down this week due to expanding quarantines, new travel bans, and the failure of Trump's payroll tax cut proposal, but the healthcare sector may take extra damage Monday as it bears the brunt of the cost of coronavirus testing.
AMEX:XLVShort
by ChristopherCarrollSmith
4
XLV breakout? Watch retest, quite possibly a fakeout.Healthcare is mirroring 2015-2016's triangle breakout pattern here with an obvious move above the trendline. LOTS of people see this, and there are many people viewing this as a repeat of the post 2015 rebound. I'm not totally sold on that scenario however. 2015-2016's healthcare consolidation saw a lot of frauds busted and companies deflated. Currently, we do not really have that environment to rebound from aside from the pharma companies who are going to be taking hits for opioid litigation, and we're facing some major political headwinds. While I can see some recovery from opioid settlements, I don't think we're past that as a risk quite yet, and we're coming to face other risks from the political process. With that said, I DO like healthcare. It tends to be less cyclical than other sectors, and unlike utilities & reit's, this defensive sector isn't going to kill you if we see a return to inflation / reflation at any point. Watch the breakout for a retest, and keep an eye on what it does. Markets love to fake people out, especially when everyone and their mother is seeing a repeat of previous patterns in play.
AMEX:XLV
by GTStockmaster